Intellia Therapeutics (NTLA) Q2 2025 Earnings

May 8Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.52
-1.38
-1.24
-1.1

Details

Expected EPS
-1.27904
Actual EPS
-1.1
Surprise EPS
0.18
Surprise Percent
+14%

Description

⁨Intellia Therapeutics⁩ (⁦NTLA⁩) has reported earnings of ⁦-1.1⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts